Radiopharm Theranostics Files 6-K
Ticker: RDPTF · Form: 6-K · Filed: Mar 17, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, reporting
TL;DR
Radiopharm Theranostics filed a 6-K on 3/17/25, confirming its foreign private issuer status and reporting obligations.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on March 17, 2025, reporting information for the month of March 2025. The company is a foreign private issuer and is subject to reporting requirements under the U.S. Securities Exchange Act of 1934. Radiopharm Theranostics Limited is incorporated in Australia and its principal executive office is located in Carlton South, Victoria.
Why It Matters
This filing indicates ongoing reporting compliance for Radiopharm Theranostics Limited with the SEC, which is important for investors tracking the company's regulatory status.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer status and does not contain new financial or operational information that would typically indicate increased risk.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- March 2025 (date) — Reporting Period
- Carlton South, Victoria, Australia (location) — Principal Executive Office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have filed or are required to file with a stock exchange on which they are traded.
What is Radiopharm Theranostics Limited's SEC file number?
Radiopharm Theranostics Limited's SEC file number is 001-41621.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is the month of March 2025.
Is Radiopharm Theranostics Limited required to file an annual report on Form 20-F?
Yes, the filing indicates that Radiopharm Theranostics Limited files or will file annual reports under cover of Form 20-F.
Where is Radiopharm Theranostics Limited's principal executive office located?
Radiopharm Theranostics Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 17, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).